Idorsia Aktie 36346343 / CH0363463438
3.20
CHF
-0.01
CHF
-0.19%
17:30:20
SWX
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
| Ausblick | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 58.65 |
| Clozel Family | 25.86 |
| Idorsia Ltd. | 5.32 |
| Johnson & Johnson | 5.10 |
| Rudolf Maag | 4.79 |
| Lazard Asset Management Ltd. | 2.83 |
| Fidelity Management & Research Co. LLC | 2.82 |
| American Funds Small Cap World Fund | 2.30 |
| Government Pension Fund - Global (The) | 1.68 |
| American Funds New Economy Fund | 1.58 |
| Longleaf Partners Small Cap Fund | 1.17 |
| Vanguard Total International Stock Index Fund | 0.87 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 941 | 775 | 1'035 | 1'077 | 596 |
| Summe Anlagevermögen | 1'249 | 816 | 1'223 | 1'268 | 566 |
| Summe Aktiva | 1'407 | 1'004 | 1'435 | 1'483 | 904 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 584 | 643 | 638 | 1'163 | 1'227 |
| Summe Fremdkapital | 749 | 840 | 850 | 1'379 | 1'565 |
| Summe Eigenkapital | 658 | 164 | 585 | 104 | -661 |
| Summe Passiva | 1'407 | 1'004 | 1'435 | 1'483 | 904 |
Adresse
| Hegenheimermattweg 91, 4123 Allschwil | |
| Telefon | +41 (58) 844-00-00 |
| URL | http://www.idorsia.com |
Management
|
Alberto Gimona
Head-Global Clinical Development & Executive VP |
|
Alexander Khatuntsev
Senior VP & Head-Global Human Resources |
|
Andrew C. Weiss
SVP, Head-Corporate Communication & IR |
|
André C. Muller
Chief Financial Officer & Executive Vice President |
|
Felix R. Ehrat
Non-Executive Director |
|
Guy Braunstein
Chief Medical Officer & Executive Vice President |
|
Jean-Paul Clozel
Chief Executive Officer & Director |
|
Julien Gander
Senior Vice President & Group General Counsel |
|
Jörn Aldag
Non-Executive Director |
|
Martine Clozel
Chief Scientific Officer & Executive VP |
|
Mathieu Simon
Chairman |
|
Peter N. Kellogg
Non-Executive Director |
|
Sandesh Mahatme
Non-Executive Director |
|
Simon Jose
Chief Commercial Officer & Executive VP |
|
Srishti Gupta
Non-Executive Director |